潤都股份(002923.SZ):擬在經營範圍中新增“幹混懸劑”
格隆匯 6 月 29日丨潤都股份(002923.SZ)公佈,由於公司業務發展需要,公司擬在經營範圍中新增“幹混懸劑”,變更後的經營範圍為:研發、生產、銷售原料藥、小容量注射劑、片劑、硬膠囊劑、幹混懸劑、製劑中間體(微丸),藥用輔料,醫藥中間體(不含危險品)。
其中,製劑和原料藥生產範圍變更後的內容如下:
(1)製劑生產範圍包括:小容量注射劑、片劑、硬膠囊劑、幹混懸劑、製劑中間體(微丸),藥用輔料(藥用微丸丸芯(蔗糖型));
(2)原料藥生產範圍包括:鹽酸伊託必利、蘭索拉唑、鹽酸伐昔洛韋、鹽酸左布比卡因、雷貝拉唑鈉、磷酸哌喹、伏立康唑、甲磺酸左氧氟沙星、泛酸鈉、尼麥角林、鹽酸去甲烏藥鹼、厄貝沙坦、纈沙坦、奧美沙坦酯、坎地沙坦酯、鹽酸莫西沙星、鹽酸度洛西汀、吉非替尼、鹽酸厄洛替尼、達沙替尼、阿齊沙坦、硫酸奎尼丁、替米沙坦、纈沙坦鈉、苯甲酸阿格列汀、拉考沙胺、沙庫巴曲鈉、沙庫巴曲纈沙坦鈉、雙氯芬酸鈉、艾司奧美拉唑鎂、鹽酸甲碸黴素甘胺酸酯、N-乙酰基-D-氨基葡萄糖、羧胺三唑、右雷佐生、硫酸羥氯喹、瑞加德鬆。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.